Results 301 to 310 of about 69,107 (331)

Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus

Nature Reviews Endocrinology, 2020
Carolyn F Deacon
exaly  

Dipeptidyl peptidase-4 (DPP-4)

Science-Business eXchange, 2012
openaire   +1 more source

Periostin and Dipeptidyl Peptidase-4

Immunology and Allergy Clinics of North America, 2018
Claire Emson, Tuyet-Hang Pham, Scott Manetz, Paul Newbold   +3 more
openaire   +1 more source

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

Endocrine Reviews, 2014
Erin E Mulvihill
exaly  

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Lancet, The, 2006
Michael A Nauck
exaly  

Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth

Nature Immunology, 2019
Clémence Hollande, Jay Boussier, James Ziai   +2 more
exaly  

MEROPS: the peptidase database

Nucleic Acids Research, 2010
Neil David Rawlings, Alan J. Barrett, Alex Bateman   +2 more
exaly  

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Nature, 2013
V Stalin Raj, Huihui Mou, Marcel A Müller   +2 more
exaly  

MEROPS: the peptidase database

Nucleic Acids Research, 2006
Neil David Rawlings, Alan J. Barrett
exaly